High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison

Item Type:	Article
Title:	High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison
Creators Name:	Hiddemann, W. and Aul, C. and Maschmeyer, G. and Schoenrock-Nabulsi, R. and Ludwig, W.D. and Bartholomaeus, A. and Bettelheim, P. and Becker, K. and Balleisen, L. and Lathan, B. and Koeppler, H. and Grueneisen, T. and Donhuijsen-Ant, R. and Reichle, A. and Heinecke, A. and Sauerland, C. and Buechner, T.
Source:	Leukemia & Lymphoma
ISSN:	1042-8194
Volume:	10 Suppl.
Page Range:	133-137
Date:	1 January 1993
PubMed:	View item in PubMed

Repository Staff Only: item control page